Antihistamines in the Treatment of Irritable Bowel Syndrome With Diarrhea: a Cross-Over Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT04612803

Title field or adapter rule

{'original_value': 'Antihistamines in the Treatment of Irritable Bowel Syndrome With Diarrhea: a Cross-Over Trial', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:34.922698+00:00

Published At

2026-09-04T00:00:00+00:00

Record Updated At

2026-09-04

Source Retrieved At

2026-10-31T22:18:48.933435+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Irritable Bowel Syndrome", "Dermatographism", "Post-prandial Diarrhea"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-09-04", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT04612803"

protocolSection.identificationModule.officialTitle

"Antihistamines in the Treatment of Irritable Bowel Syndrome With Diarrhea: a Cross-Over Trial"

protocolSection.statusModule.overallStatus

"WITHDRAWN"

protocolSection.designModule.phases

["PHASE3"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Irritable Bowel Syndrome (protocolSection.conditionsModule.conditions)
• Dermatographism (protocolSection.conditionsModule.conditions)
• Post-prandial Diarrhea (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Intervention Arm'], 'description': 'Cetirizine 10 mg and famotidine 20 mg will be dispensed to each patient, to be taken twice a day at 6-9AM one hour before eating breakfast and again at evening 12 hours after the morning dose for 30 days', 'name': 'Antihistamine', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Placebo'], 'description': 'These medications will be pre-packaged by the UC Health pharmacy in a manner that results in a double-blinded cross-over design.', 'name': 'Placebo', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• Antihistamine (protocolSection.armsInterventionsModule.interventions[].name)
• Placebo (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.